Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer
<p dir="ltr">We read with great interest the recently published review by Jing W et al. (1) on the relevance of the cancer testis antigen (CTA) Lactate Dehydrogenase C (LDHC) in male infertility and cancer. In their review, the authors discussed the mechanisms by which LDHC regulates...
Saved in:
| Main Author: | A. Naik (7783220) (author) |
|---|---|
| Other Authors: | J. Decock (7707326) (author) |
| Published: |
2023
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
by: Remy Thomas (702843)
Published: (2020) -
Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy
by: Adviti Naik (673163)
Published: (2021) -
Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
by: Adviti Naik (673163)
Published: (2022) -
Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?
by: Ghaneya Al-Khadairi (14153274)
Published: (2019) -
Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
by: Afsheen Raza (492657)
Published: (2022)